GM-CSF has been studied in various types of cancer, including melanoma, non-small cell lung cancer, and prostate cancer. In melanoma, for example, GM-CSF has been used in combination with other immunotherapies to enhance the overall immune response. Researchers are also investigating its potential in hematologic malignancies like leukemias and lymphomas.
